ahlam1399
08-05-2016, 01:18 AM
U.S. panel backs approval of Egalet?s abuse-resistant painkiller
WASHINGTON (Reuters) - A U.S. advisory panel on Thursday recommended approval of Egalet Corp's long-acting opioid painkiller, Arymo ER, saying it dulls pain and could deter abuse by addicts seeking a quick high.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=JRJT7oOq7FI:RouZq7iyiDk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JRJT7oOq7FI:RouZq7iyiDk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=JRJT7oOq7FI:RouZq7iyiDk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JRJT7oOq7FI:RouZq7iyiDk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=JRJT7oOq7FI:RouZq7iyiDk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/JRJT7oOq7FI
WASHINGTON (Reuters) - A U.S. advisory panel on Thursday recommended approval of Egalet Corp's long-acting opioid painkiller, Arymo ER, saying it dulls pain and could deter abuse by addicts seeking a quick high.http://feeds.feedburner.com/~ff/reuters/healthNews?d=yIl2AUoC8zA (http://feeds.reuters.com/~ff/reuters/healthNews?a=JRJT7oOq7FI:RouZq7iyiDk:yIl2AUoC8zA) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JRJT7oOq7FI:RouZq7iyiDk:F7zBnMyn0Lo (http://feeds.reuters.com/~ff/reuters/healthNews?a=JRJT7oOq7FI:RouZq7iyiDk:F7zBnMyn0Lo) http://feeds.feedburner.com/~ff/reuters/healthNews?i=JRJT7oOq7FI:RouZq7iyiDk:V_sGLiPBpWU (http://feeds.reuters.com/~ff/reuters/healthNews?a=JRJT7oOq7FI:RouZq7iyiDk:V_sGLiPBpWU)
http://feeds.feedburner.com/~r/reuters/healthNews/~4/JRJT7oOq7FI